NDC 71335-1296 – Buprenorphine and Naloxone

Buprenorphine 2 mg/1; Naloxone .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1296

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205022
Marketed since
September 19, 2016
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (2)

Package NDCDescriptionSince
71335-1296-130 TABLET in 1 BOTTLE (71335-1296-1)Aug 12, 2019
71335-1296-210 TABLET in 1 BOTTLE (71335-1296-2)May 17, 2024

Other Buprenorphine and Naloxone products